SINGAPORE – Premature ejaculation, the bane of many men in Singapore, could soon be a thing of the past when a new medication is made available here in March.
Priligy, the world’s first oral medication for the treatment of the affliction that apparently affects one third of Singaporean men aged between 18 and 59 according to a recent study – has been approved for use in Singapore.
Priligy was subjected to a clinical trial in the Asia-Pacific region, including Singapore, where participants received the medication (one to three hours before intercourse) for 12 weeks.
Participants reported an average of three-fold improvement in duration of intercourse time.
At the end of the trial, a significant 33.5 per cent of the men reported “good” or “very good” control over ejaculation compared with between 0.9 and 1.6 per cent before the trial.
Three quarters of these men reported an increase in satisfaction with sexual intercourse.
At the start of the trial, close to three-quarters of the men reported they were “quite a bit” or “extremely” distressed about their speed of ejaculation.
By the end of the trial this had fallen to about a quarter.
Professor Peter Lim, president of the Society for Men’s Health Singapore and senior consultant in Urology at Gleneagles Hospital, said the new treatment will give new hope to many men who struggle with this condition. CLEMENT MESENAS